Imunon 미래 성장
Future 기준 확인 0/6
Imunon's earnings are forecast to decline at 19.6% per annum while its annual revenue is expected to grow at 82.9% per year. EPS is expected to grow by 36% per annum.
주요 정보
-19.6%
수익 성장률
36.0%
EPS 성장률
Biotechs 수익 성장 | 36.4% |
매출 성장률 | 82.9% |
향후 자기자본 수익률 | n/a |
애널리스트 커버리지 | Low |
마지막 업데이트 | 31 Oct 2024 |
최근 미래 성장 업데이트
업데이트 없음
Recent updates
수익 및 매출 성장 예측
날짜 | 수익 | 수익 | 잉여 현금 흐름 | 작전 현금 | 평균 애널리스트 수 |
---|---|---|---|---|---|
12/31/2026 | N/A | -35 | -45 | -46 | 4 |
12/31/2025 | N/A | -27 | -37 | -34 | 4 |
12/31/2024 | N/A | -22 | -29 | -29 | 4 |
6/30/2024 | N/A | -18 | -19 | -19 | N/A |
3/31/2024 | N/A | -19 | -21 | -21 | N/A |
12/31/2023 | N/A | -20 | -19 | -19 | N/A |
9/30/2023 | 0 | -28 | -21 | -20 | N/A |
6/30/2023 | 0 | -31 | -21 | -20 | N/A |
3/31/2023 | 0 | -31 | -19 | -19 | N/A |
12/31/2022 | 1 | -36 | -23 | -23 | N/A |
9/30/2022 | 1 | -27 | -23 | -23 | N/A |
6/30/2022 | 1 | -26 | -23 | -22 | N/A |
3/31/2022 | 1 | -26 | -20 | -19 | N/A |
12/31/2021 | 1 | -21 | -17 | -16 | N/A |
9/30/2021 | 1 | -20 | -15 | -15 | N/A |
6/30/2021 | 1 | -22 | -15 | -15 | N/A |
3/31/2021 | 1 | -22 | -16 | -15 | N/A |
12/31/2020 | 1 | -21 | -16 | -16 | N/A |
9/30/2020 | 1 | -22 | -18 | -18 | N/A |
6/30/2020 | 1 | -19 | -18 | -18 | N/A |
3/31/2020 | 1 | -20 | -20 | -20 | N/A |
12/31/2019 | 1 | -17 | -21 | -20 | N/A |
9/30/2019 | 1 | -8 | -9 | -9 | N/A |
6/30/2019 | 1 | -7 | -9 | -8 | N/A |
3/31/2019 | 1 | -10 | -8 | -8 | N/A |
12/31/2018 | 1 | -12 | -7 | -7 | N/A |
9/30/2018 | 1 | -22 | -17 | -17 | N/A |
6/30/2018 | 1 | -23 | -18 | -18 | N/A |
3/31/2018 | 1 | -20 | N/A | -18 | N/A |
12/31/2017 | 1 | -21 | N/A | -17 | N/A |
9/30/2017 | 1 | -21 | N/A | -17 | N/A |
6/30/2017 | 1 | -22 | N/A | -17 | N/A |
3/31/2017 | 1 | -21 | N/A | -17 | N/A |
12/31/2016 | 1 | -22 | N/A | -18 | N/A |
9/30/2016 | 1 | -22 | N/A | -18 | N/A |
6/30/2016 | 1 | -20 | N/A | -18 | N/A |
3/31/2016 | 1 | -21 | N/A | -20 | N/A |
12/31/2015 | 1 | -22 | N/A | -21 | N/A |
9/30/2015 | 1 | -23 | N/A | -23 | N/A |
6/30/2015 | 1 | -26 | N/A | -24 | N/A |
3/31/2015 | 1 | -27 | N/A | -22 | N/A |
12/31/2014 | 1 | -25 | N/A | -21 | N/A |
9/30/2014 | 1 | -23 | N/A | -18 | N/A |
6/30/2014 | 1 | -20 | N/A | -15 | N/A |
3/31/2014 | 1 | -13 | N/A | -16 | N/A |
12/31/2013 | 1 | -13 | N/A | -10 | N/A |
애널리스트 미래 성장 예측
수입 대 저축률: CBO is forecast to remain unprofitable over the next 3 years.
수익 vs 시장: CBO is forecast to remain unprofitable over the next 3 years.
고성장 수익: CBO is forecast to remain unprofitable over the next 3 years.
수익 대 시장: CBO is forecast to have no revenue next year.
고성장 수익: CBO is forecast to have no revenue next year.
주당 순이익 성장 예측
미래 자기자본 수익률
미래 ROE: Insufficient data to determine if CBO's Return on Equity is forecast to be high in 3 years time